Structure Therapeutics Inc. (GPCR) ROE
- 2026-06-30: ROE -15.86%.
- 2026-03-31: ROE -11.77%.
- 2025-12-31: ROE -9.31%.
- 2025-09-30: ROE -27.36%.
Complete source-backed roe history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -15.86% |
| 2026-03-31 | -11.77% |
| 2025-12-31 | -9.31% |
| 2025-09-30 | -27.36% |
| 2025-06-30 | -23.18% |
| 2025-03-31 | -17.38% |
| 2024-12-31 | -14.17% |
| 2024-09-30 | -12.33% |
| 2024-06-30 | -10.90% |
| 2024-03-31 | -22.73% |
| 2023-12-31 | -19.79% |
| 2023-09-30 | -39.90% |
| 2023-06-30 | -30.57% |
| 2023-03-31 | -23.78% |
| 2022-12-31 | 44.57% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -9.31% |
| 2024-12-31 | -14.17% |
| 2023-12-31 | -19.79% |
| 2022-12-31 | 44.57% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |